Relaxin causes selective outward remodeling of brain parenchymal arterioles via activation of peroxisome proliferator-activated receptor-γ

FASEB Journal

Volumn 25, Issue 9, 2011, Pages 3229-3239

  Chan, Siu Lung ^a   Cipolla, Marilyn J ^a  

^a UNIVERSITY OF VERMONT   (United States)

Author keywords

Hypertrophy; Middle cerebral arteries; Myogenic reactivity

Indexed keywords

2 CHLORO 5 NITROBENZANILIDE; CD36 ANTIGEN; COMPLEMENTARY DNA; LIVER X RECEPTOR ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PLASMINOGEN ACTIVATOR INHIBITOR 1; RELAXIN;

ADIPOSE TISSUE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTERIAL WALL THICKNESS; ARTERIOLE; ARTERY DIAMETER; ARTICLE; BLOOD LEVEL; BLOOD VESSEL REACTIVITY; BRAIN PARENCHYMAL ARTERIOLE; CARDIOVASCULAR FUNCTION; CONTROLLED STUDY; GENE EXPRESSION; GENE TARGETING; HYPOTROPHIC OUTWARD REMODELING; MESENTERIC ARTERY; MIDDLE CEREBRAL ARTERY; MUSCLE CONTRACTION; NONHUMAN; PIA ARTERY; PREGNANCY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RAT; REAL TIME POLYMERASE CHAIN REACTION; RENAL ARTERY; VASCULAR BIOLOGY; VASCULAR CAPACITY; VASCULAR ENDOTHELIUM; VASCULARIZATION; VASOCONSTRICTION;

ANILIDES; ANIMALS; ARTERIOLES; BRAIN; FEMALE; GENE EXPRESSION REGULATION; MIDDLE CEREBRAL ARTERY; PPAR GAMMA; PREGNANCY; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, G-PROTEIN-COUPLED; RECEPTORS, PEPTIDE; RELAXIN;

ANIMALIA; RATTUS;

EID: 80052652796     PISSN: 08926638     EISSN: 15306860     Source Type: Journal    
DOI: 10.1096/fj.10-175471     Document Type: Article

References (52)

1. Sherwood, O. D. (2004) Relaxin's physiological roles and other diverse actions. Endocr. Rev. 25, 205-234
2. Sherwood, O. D. (1994) Relaxin. In The Physiology of Reproduction, Vol. 1 (Knobil, E., and Neill, J. D., eds) pp. 861-1009, Raven, New York
3. Bathgate, R. A., Ivell, R., Sanborn, B. M., Sherwood, O. D., and Summers, R. J. (2006) International Union of Pharmacology LVII: recommendations for the nomenclature of receptors for relaxin family peptides. Pharmacol. Rev. 58, 7-31
4. Bani, D. (2008) Relaxin as a natural agent for vascular health. Vasc. Health Risk Manag. 4, 515-524
5. Conrad, K. P., and Novak, J. (2004) Emerging role of relaxin in renal and cardiovascular function. Am. J. Physiol. Regul. Integr. Comp. Physiol. 287, R250-R261 (Pubitemid 38970272)
6. Teerlink, J. R., Metra, M., Felker, G. M., Ponikowski, P., Voors, A. A., Weatherley, B. D., Marmor, A., Katz, A., Grzybowski, J., Unemori, E., Teichman, S. L., and Cotter, G. (2009) Relaxin for the treatment of patients with acute heart failure (Pre-RELAX-AHF): a multicentre, randomised, placebo-controlled, parallel-group, dose-finding phase IIb study. Lancet 373, 1429 -1439
7. Unemori, E., Sibai, B., and Teichman, S. L. (2009) Scientific rationale and design of a phase I safety study of relaxin in women with severe preeclampsia. Ann. N. Y. Acad. Sci. 1160, 381-384
8. Debrah, D. O., Conrad, K. P., Danielson, L. A., and Shroff, S. G. (2005) Effects of relaxin on systemic arterial hemodynamics and mechanical properties in conscious rats: sex dependency and dose response. J. Appl. Physiol. 98, 1013-1020 (Pubitemid 40283683)
9. Conrad, K. P., Debrah, D. O., Novak, J., Danielson, L. A., and Shroff, S. G. (2004) Relaxin modifies systemic arterial resistance and compliance in conscious, nonpregnant rats. Endocrinology 145, 3289-3296 (Pubitemid 38830001)
10. Danielson, L. A., and Conrad, K. P. (2003) Time course and dose response of relaxin-mediated renal vasodilation, hyperfiltration, and changes in plasma osmolality in conscious rats. J. Appl. Physiol. 95, 1509-1514 (Pubitemid 37169295)
11. Debrah, D. O., Novak, J., Matthews, J. E., Ramirez, R. J., Shroff, S. G., and Conrad, K. P. (2006) Relaxin is essential for systemic vasodilation and increased global arterial compliance during early pregnancy in conscious rats. Endocrinology 147, 5126 -5131
12. Novak, J., Danielson, L. A., Kerchner, L. J., Sherwood, O. D., Ramirez, R. J., Moalli, P. A., and Conrad, K. P. (2001) Relaxin is essential for renal vasodilation during pregnancy in conscious rats. J. Clin. Invest. 107, 1469-1475 (Pubitemid 32522041)
13. Samuel, C. S., and Hewitson, T. D. (2006) Relaxin in cardiovascular and renal disease. Kidney Int. 69, 1498-1502
14. Cipolla, M. J., and Bullinger, L. (2008) Pregnancy decreases cerebrovascular resistance and increases blood-brain barrier permeability during acute hypertension: a role in eclampsia? Reprod. Sci. 15, 288A
15. Williams, K. P., and Wilson, S. (1998) Variation in cerebral perfusion pressure with different hypertensive states in pregnancy. Am. J. Obstet. Gynecol. 179, 1200-1203 (Pubitemid 28533771)
16. Cipolla, M. J., and Sweet, J. G. (2008) Pregnancy decreases myogenic activity of brain parenchymal arterioles: role of estrogen. FASEB J. 22, 1151-1158
17. Faraci, F. M., and Heistad, D. D. (1990) Regulation of large cerebral arteries and cerebral microvascular pressure. Circ. Res. 66, 8-17 (Pubitemid 20033921)
18. Pohl, U., De Wit, C., and Gloe, T. (2000) Large arterioles in the control of blood flow: role of endothelium-dependent dilation. Acta Physiol. Scand. 168, 505-510 (Pubitemid 30197887)
19. Beyer, A. M., Baumbach, G. L., Halabi, C. M., Modrick, M. L., Lynch, C. M., Gerhold, T. D., Ghoneim, S. M., De Lange, W. J., Keen, H. L., Tsai, Y. S., Maeda, N., Sigmund, C. D., and Faraci, F. M. (2008) Interference with PPARγ signaling causes cerebral vascular dysfunction, hypertrophy, and remodeling. Hypertension 51, 867-871 (Pubitemid 351654697)
20. Waite, L. L., Louie, R. E., and Taylor, R. N. (2005) Circulating activators of peroxisome proliferator-activated receptors are reduced in preeclamptic pregnancy. J. Clin. Endocrinol. Metab. 90, 620-626 (Pubitemid 40279171)
21. Wieser, F., Waite, L., Depoix, C., and Taylor, R. N. (2008) PPAR action in human placental development and pregnancy and its complications. PPAR Res. 2008, 527048
22. Cipolla, M. J., Bullinger, L., and Godfrey, J. (2009) Pregnancy and PPARg activation cause small vessel remodeling in the maternal brain and diminished cerebrovascular resistance: a role in eclampsia? Reprod Sci. 16, 91A
23. Cipolla, M. J., Chan, S.-L., Chapman, A. C., and Godfrey, J. A. (2010) Inhibition of PPARγ during pregnancy causes inward remodeling of brain parenchymal arterioles. FASEB J. 24, 979.4 (abstr.)
24. Singh, S., and Bennett, R. G. (2010) Relaxin signaling activates peroxisome proliferator-activated receptor gamma. Mol. Cell. Endocrinol. 315, 239-245
25. Cipolla, M. J., and Bullinger, L. V. (2008) Reactivity of brain parenchymal arterioles after ischemia and reperfusion. Microcirculation 15, 495-501
26. Cipolla, M. J., Smith, J., Kohlmeyer, M. M., and Godfrey, J. A. (2009) SKCa and IKCa channels, myogenic tone, and vasodilator responses in middle cerebral arteries and parenchymal arterioles: effect of ischemia and reperfusion. Stroke 40, 1451-1457
27. Livak, K. J., and Schmittgen, T. D. (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2[-Delta Delta C(T)] method. Methods 25, 402-408 (Pubitemid 34164012)
28. Li, Y., Brookes, Z. L., and Kaufman, S. (2005) Acute and chronic effects of relaxin on vasoactivity, myogenic reactivity and compliance of the rat mesenteric arterial and venous vasculature. Regul. Pept. 132, 41-46 (Pubitemid 41607501)
29. Novak, J., Ramirez, R. J., Gandley, R. E., Sherwood, O. D., and Conrad, K. P. (2002) Myogenic reactivity is reduced in small renal arteries isolated from relaxin-treated rats. Am. J. Physiol. Regul. Integr. Comp. Physiol. 283, R349-R355 (Pubitemid 34863882)
30. Cipolla, M. J., Li, R., and Vitullo, L. (2004) Perivascular innervation of penetrating brain parenchymal arterioles. J. Cardiovasc. Pharmacol. 44, 1-8 (Pubitemid 38857122)
31. Jeyabalan, A., Kerchner, L. J., Fisher, M. C., McGuane, J. T., Doty, K. D., and Conrad, K. P. (2006) Matrix metalloproteinase-2 activity, protein, mRNA, and tissue inhibitors in small arteries from pregnant and relaxin-treated nonpregnant rats. J. Appl. Physiol. 100, 1955-1963 (Pubitemid 43845871)
32. Jeyabalan, A., Novak, J., Danielson, L. A., Kerchner, L. J., Opett, S. L., and Conrad, K. P. (2003) Essential role for vascular gelatinase activity in relaxin-induced renal vasodilation, hyperfiltration, and reduced myogenic reactivity of small arteries. Circ. Res. 93, 1249-1257 (Pubitemid 37543066)
33. Cipolla, M. J., Sweet, J. G., and Chan, S. L. (2011) Cerebral vascular adaptation to pregnancy and its role in the neurological complications of eclampsia. J. Appl. Physiol. 110, 329 -339
34. Fournier, T., Therond, P., Handschuh, K., Tsatsaris, V., and Evain-Brion, D. (2008) PPARgamma and early human placental development. Curr. Med. Chem. 15, 3011-3024
35. Toth, B., Hornung, D., Scholz, C., Djalali, S., Friese, K., and Jeschke, U. (2007) Peroxisome proliferator-activated receptors: new players in the field of reproduction. Am. J. Reprod. Immunol. 58, 289-310 (Pubitemid 47249067)
36. Arck, P., Toth, B., Pestka, A., and Jeschke, U. Nuclear receptors of the peroxisome proliferator-activated receptor (PPAR) family in gestational diabetes: from animal models to clinical trials. Biol. Reprod. 83, 168-176
37. Halabi, C. M., Beyer, A. M., De Lange, W. J., Keen, H. L., Baumbach, G. L., Faraci, F. M., and Sigmund, C. D. (2008) Interference with PPAR gamma function in smooth muscle causes vascular dysfunction and hypertension. Cell Metab. 7, 215-226 (Pubitemid 351285526)
38. Tsai, Y. S., Kim, H. J., Takahashi, N., Kim, H. S., Hagaman, J. R., Kim, J. K., and Maeda, N. (2004) Hypertension and abnormal fat distribution but not insulin resistance in mice with P465L PPARγ. J. Clin. Invest. 114, 240-249 (Pubitemid 39071629)
39. Dello Russo, C., Gavrilyuk, V., Weinberg, G., Almeida, A., Bolanos, J. P., Palmer, J., Pelligrino, D., Galea, E., and Feinstein, D. L. (2003) Peroxisome proliferator-activated receptor gamma thiazolidinedione agonists increase glucose metabolism in astrocytes. J. Biol. Chem. 278, 5828-5836 (Pubitemid 36800829)
40. Baumbach, G. L. (1996) Effects of increased pulse pressure on cerebral arterioles. Hypertension 27, 159-167
41. Baumbach, G. L., and Chillon, J. M. (2000) Effects of angiotensin-converting enzyme inhibitors on cerebral vascular structure in chronic hypertension. J. Hypertens. Suppl. 18, S7-S11 (Pubitemid 30487406)
42. Baumbach, G. L., Heistad, D. D., and Siems, J. E. (1989) Effect of sympathetic nerves on composition and distensibility of cerebral arterioles in rats. J. Physiol. 416, 123-140 (Pubitemid 19223207)
43. Baumbach, G. L., Sigmund, C. D., and Faraci, F. M. (2003) Cerebral arteriolar structure in mice overexpressing human renin and angiotensinogen. Hypertension 41, 50-55 (Pubitemid 36056791)
44. Baumbach, G. L., Sigmund, C. D., and Faraci, F. M. (2004) Structure of cerebral arterioles in mice deficient in expression of the gene for endothelial nitric oxide synthase. Circ. Res. 95, 822-829 (Pubitemid 39390585)
45. 2+-superoxide dismutase and decrease p22phox message expressions in primary endothelial cells. Metabolism 50, 3-11
46. Sugawara, A., Takeuchi, K., Uruno, A., Ikeda, Y., Arima, S., Kudo, M., Sato, K., Taniyama, Y., and Ito, S. (2001) Transcriptional suppression of type 1 angiotensin II receptor gene expression by peroxisome proliferator-activated receptor-gamma in vascular smooth muscle cells. Endocrinology 142, 3125-3134 (Pubitemid 32575551)
47. Diep, Q. N., El Mabrouk, M., Cohn, J. S., Endemann, D., Amiri, F., Virdis, A., Neves, M. F., and Schiffrin, E. L. (2002) Structure, endothelial function, cell growth, and inflammation in blood vessels of angiotensin II-infused rats: role of peroxisome proliferator-activated receptor-gamma. Circulation 105, 2296 -2302
48. Chillon, J. M., and Baumbach, G. L. (1999) Effects of an angiotensin-converting enzyme inhibitor and a beta-blocker on cerebral arterioles in rats. Hypertension 33, 856-861
49. Jeyabalan, A., Novak, J., Doty, K. D., Matthews, J., Fisher, M. C., Kerchner, L. J., and Conrad, K. P. (2007) Vascular matrix metalloproteinase-9 mediates the inhibition of myogenic reactivity in small arteries isolated from rats after short-term administration of relaxin. Endocrinology 148, 189-197 (Pubitemid 46023450)
50. Desan, P. H., Woodmansee, W. W., Ryan, S. M., Smock, T. K., and Maier, S. F. (1988) Monoamine neurotransmitters and metabolites during the estrous cycle, pregnancy, and the postpartum period. Pharmacol. Biochem. Behav. 30, 563-568 (Pubitemid 19271135)
51. Gregg, C. (2009) Pregnancy, prolactin and white matter regeneration. J. Neurol. Sci. 285, 22-27
52. Chan, S.-L., Chapman, A. C., Sweet, J. G., Gokina, N. I., and Cipolla, M. J. (2010) Effect of PPARγ inhibition during pregnancy on posterior cerebral artery function and structure. Front. Vasc. Physiol. 1, 12